Business

SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution

SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution.

articleSohm, Inc.November 30, 20214/company/sohm-inc/news/sohm-inc-collaborates-for-commercial-manufacturing-of-brainwiser-a-patented-omega-3-formula-for-global-distribution
SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution

About this update from Sohm, Inc.

[{"type":"text","content":"This collaboration expands SOHM, Inc's manufacturing, and distribution footprint into Africa with an estimated $7,500,000 in revenue over 3 years.CHINO HILLS, CA / ACCESSWIRE / November 30, 2021 / SOHM, Inc. (OTC PINK:SHMN), a Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets nutraceuticals covering numerous treatment categories presents information about Brainwise®, an innovative nutraceutical product through its collaboration with African based "J" Source Industries.Mr. Baron Night, President and CEO of SOHM Inc., said, "The proprietary method in which this omega 3 formula is created provides a pathway to solving a deficiency which is becoming more and more prevalent in today's population. Our collaboration with "J" Source Industries brings tremendous revenue opportunity to SOHM with plans for commercial manufacturing and global distribution of this amazing product."Details of the collaboration include a 3-year exclusive manufacturing and distribution agreement which expands SOHM's product portfolio to include this patented formula with initial 3-year revenue projections upwards of $7,500,000 for the African markets alone. 16-month revenues are an estimated $2,880,000 of which the first purchase order valued at $750,000 has been received. Planned distribution channels include the much sought-after continent of Africa as well as North America and the Middle East. "This collaboration brings tremendous revenue opportunity especially in the North American market and it further delivers on SOHM's vision of Globalè Prospèro", added Mr. Night.Brainwise® plays a significant role in sharpening memory and improving mood while protecting the brain against cognitive decline. In clinical studies, Omega 3 has been shown in clinical studies to help patients with Autism, ADHD, Dyslexia, and other common developmental disorders of learning and behavior. Brainwise® contains no bioengineered ingredients (No GMO), is gluten-free, and free from heavy metals furthering the Company's mission to provide superior health solutions towards a healthy world. This product is currently being used by children ages 2 and up as well as senior citizens in need of improved brain health.Mr. Night continued, "We welcome this collaboration and expect tremendou...

More updates from Sohm, Inc.